Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDInhibrx Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$2.84 | -$2.84 | -$2.84 |
| Q2 2025 | 1 | -$2.76 | -$2.76 | -$2.76 |
| Q3 2025 | 1 | -$2.80 | -$2.80 | -$2.80 |
| Q4 2025 | 1 | -$2.85 | -$2.85 | -$2.85 |
| Q1 2026 | 1 | -$2.48 | -$2.48 | -$2.48 |
| Q2 2026 | 1 | -$2.25 | -$2.25 | -$2.25 |
| Q3 2026 | 1 | -$2.24 | -$2.24 | -$2.24 |
| Q4 2026 | 1 | -$2.28 | -$2.28 | -$2.28 |
Inhibrx Biosciences, Inc. Earnings Date And Information
Inhibrx Biosciences, Inc. last posted its earnings results on Wednesday, May 14th, 2025. The company reported $-2.8 earnings per share for the quarter, missing analysts' consensus estimates of $-2.55 by $0.25. The company had revenue of 0 for the quarter and had revenue of 200.00 K for the year. Inhibrx Biosciences, Inc. has generated $114 earnings per share over the last year ($112.62 diluted earnings per share) and currently has a price-to-earnings ratio of 0.13. Inhibrx Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based on prior year's report dates.
Inhibrx Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2025 | Q1 2025 | -$2.55 | -$2.80 | -0.25 | $0 | $0 |
| 03/17/2025 | Q4 2024 | -$2.88 | -$3.23 | -0.35 | $50.00 K | $100.00 K |
| 11/14/2024 | Q3 2024 | -$3.06 | -$2.84 | 0.22 | $50.00 K | $0 |
| 08/13/2024 | Q2 2024 | -$3.60 | $128.35 | 131.95 | $50.00 K | $100.00 K |
| 05/09/2024 | Q1 2024 | N/A | -$1.44 | N/A | $50.00 K | $0 |
| 02/28/2024 | Q4 2023 | -$1.07 | -$1.73 | -0.66 | $50.00 K | $1.63 M |
| 11/09/2023 | Q3 2023 | -$1.01 | -$1.10 | -0.09 | N/A | $119.00 K |
| 08/07/2023 | Q2 2023 | -$1.02 | -$1.08 | -0.06 | $1.18 M | $30.00 K |
| 05/08/2023 | Q1 2023 | -$0.84 | -$1.12 | -0.28 | $100.00 K | $17.00 K |
| 03/06/2023 | Q4 2022 | -$0.80 | -$0.95 | -0.15 | $994.00 K | $274.00 K |
| 11/07/2022 | Q3 2022 | -$1.01 | -$1.04 | -0.03 | $633.33 K | $278.00 K |
| 08/08/2022 | Q2 2022 | -$0.84 | -$0.97 | -0.13 | $1.07 M | $711.00 K |
| 05/09/2022 | Q1 2022 | -$0.62 | -$0.86 | -0.24 | $1.10 M | $915.00 K |
| 02/28/2022 | Q4 2021 | -$0.53 | -$0.55 | -0.02 | $1.21 M | $2.84 M |
| 11/09/2021 | Q3 2021 | -$0.57 | -$0.54 | 0.03 | $1.00 M | $2.51 M |
| 08/09/2021 | Q2 2021 | -$0.51 | -$0.55 | -0.04 | $825.00 K | $918.00 K |
| 05/13/2021 | Q1 2021 | -$0.61 | -$0.51 | 0.1 | $925.00 K | $863.00 K |
| 03/12/2021 | Q4 2020 | -$0.50 | -$0.47 | 0.03 | $994.00 K | $2.78 M |
| 11/13/2020 | Q3 2020 | -$0.60 | -$0.77 | -0.17 | $1.00 M | $5.83 M |
| 06/29/2020 | Q2 2020 | N/A | -$0.50 | N/A | N/A | $3.33 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibrx Biosciences, Inc. Earnings: FAQ's
Inhibrx Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based offlast year's report dates.
The conference call for Inhibrx Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Inhibrx Biosciences, Inc.'s latest earnings report can be read online.
Inhibrx Biosciences, Inc. (:INBX) has a recorded annual revenue of $200.00 K.
Inhibrx Biosciences, Inc. (:INBX) has a recorded net income of $1.69 B.Inhibrx Biosciences, Inc. has generated $114.01 earnings per share over the last four quarters.
Inhibrx Biosciences, Inc. (:INBX) has a price-to-earnings ratio of 0.13 and price/earnings-to-growth ratio is -0.12.